Artwork

Content provided by Drug Discovery World and Drug Discovery World (DDW). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Drug Discovery World and Drug Discovery World (DDW) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

A safer option to opioid pain killers

15:09
 
Distribuie
 

Manage episode 398166123 series 1919400
Content provided by Drug Discovery World and Drug Discovery World (DDW). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Drug Discovery World and Drug Discovery World (DDW) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Dr Lynn Kirkpatrick, CEO of Ensysce Biosciences. As we all know, the opioid epidemic is one of the biggest issues in the United States today. As of late, it has been cracked down on to prevent overdosing and abuse of opioids, but it still leaves patients with a need for pain medication. Currently, Ensynsce Biosciences is headed into Phase III clinical trials with a drug that improves the care and safety of patients by preventing the possibility of both abuse and overdose of prescription drugs. Today, CEO Dr Kirkpatrick talks about how they are developing this safer option to opioid pain killers, and how it prevents abuse and overdose.

You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

  continue reading

156 episoade

Artwork
iconDistribuie
 
Manage episode 398166123 series 1919400
Content provided by Drug Discovery World and Drug Discovery World (DDW). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Drug Discovery World and Drug Discovery World (DDW) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Dr Lynn Kirkpatrick, CEO of Ensysce Biosciences. As we all know, the opioid epidemic is one of the biggest issues in the United States today. As of late, it has been cracked down on to prevent overdosing and abuse of opioids, but it still leaves patients with a need for pain medication. Currently, Ensynsce Biosciences is headed into Phase III clinical trials with a drug that improves the care and safety of patients by preventing the possibility of both abuse and overdose of prescription drugs. Today, CEO Dr Kirkpatrick talks about how they are developing this safer option to opioid pain killers, and how it prevents abuse and overdose.

You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

  continue reading

156 episoade

Kaikki jaksot

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință